Skip to main content

Animations

MJFF Publications

1871 - 1880 of 9156 Results
Title
Year
  • Year
  • 2016
  • 2010
  • 2012
  • 2017
  • 2015
  • 2008
  • 2012
  • 2015
  • 2008
  • 2009
  • Summary Details
    OPEN
    Title: Fbxl18 targets LRRK2 for proteasomal degradation and attenuates cell toxicity
    Journal Name: Neurobiology of Disease
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.nbd.2016.11.004
    Citation Count: 17
  • Summary Details
    OPEN
    Title: Impaired dopaminergic neurotransmission and microtubule-associated protein tau alterations in human LRRK2 transgenic mice
    Journal Name: Neurobiology of Disease
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.nbd.2010.07.010
    Citation Count: 279
  • Testing NF-κB-based Therapy in Hemiparkinsonian Monkeys
    2012
    Summary Details
    RESTRICTED
    Title: Testing NF-κB-based Therapy in Hemiparkinsonian Monkeys
    Journal Name: Journal of Neuroimmune Pharmacology
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1007/s11481-012-9377-9
    Citation Count: 42
  • Summary Details
    OPEN
    Title: MicroRNA-101 Modulates Autophagy and Oligodendroglial Alpha-Synuclein Accumulation in Multiple System Atrophy
    Journal Name: Frontiers in Molecular Neuroscience
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fnmol.2017.00329
    Citation Count: 55
  • Summary Details
    OPEN
    Title: Neuromelanin activates proinflammatory microglia through a caspase-8-dependent mechanism
    Journal Name: Journal of Neuroinflammation
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s12974-014-0228-x
    Citation Count: 63
  • Summary Details
    OPEN
    Title: The synaptic impact of the host immune response in a parkinsonian allograft rat model: Influence on graft-derived aberrant behaviors
    Journal Name: Neurobiology of Disease
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.nbd.2008.06.018
    Citation Count: 65
  • Summary Details
    OPEN
    Title: CD4+ Regulatory and Effector/Memory T Cell Subsets Profile Motor Dysfunction in Parkinson’s Disease
    Journal Name: Journal of Neuroimmune Pharmacology
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1007/s11481-012-9402-z
    Citation Count: 327
  • Summary Details
    OPEN
    Title: Therapeutic deep brain stimulation reduces cortical phase-amplitude coupling in Parkinson's disease
    Journal Name: Nature Neuroscience
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1038/nn.3997
    Citation Count: 647
  • Summary Details
    OPEN
    Title: Parkin mediates the degradation‐independent ubiquitination of Hsp70
    Journal Name: Journal of Neurochemistry
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1111/j.1471-4159.2008.05261.x
    Citation Count: 100
  • Summary Details
    OPEN
    Title: A novel transferrin/TfR2-mediated mitochondrial iron transport system is disrupted in Parkinson's disease
    Journal Name: Neurobiology of Disease
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.nbd.2009.02.009
    Citation Count: 196
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.